Skip to content

Why SIG 2.0?

SIG 1.0 showed that a structured, pharmacist-led, multi-vendor methodology can deliver concrete, openly accessible interoperability standards. Its scope, however, was limited to automation devices. The wider medication management ecosystem, prescribing systems, pharmacy software, dispensing platforms and other digital solutions still lacks a comparable vendor-neutral framework for exchanging information, even as these systems grow more complex and more central to safe medication use. 

Building on this foundation, EAHP is launching SIG 2.0, “Advancing Interoperability in Closed-Loop Medication Management,” to extend the SIG methodology beyond automation devices toward a broader, plug-and-play closed-loop ecosystem. As with SIG 1.0, the detailed use cases will be selected and prioritised by participating hospital pharmacists, keeping the initiative responsive to real clinical needs rather than fixed in advance. 

Scope of activity 

Recognising that fragmented interoperability across the medication management process carries direct consequences for patient safety and pharmacy efficiency, SIG 2.0 extends EAHP’s multi-vendor, pharmacist-driven approach to a broader set of systems and use cases. 

The SIG aims to: 

Reuse and extend the methodology, tools and collaborative framework developed during SIG 1.0.

Build upon the existing FHIR Implementation Guide and its related outputs.

Expand interoperability toward dispensing, prescribing and the wider software ecosystem, beyond automation devices alone.

Explore more advanced interoperability scenarios, including patient-specific dispensing and other complex workflows.

Validate the resulting interoperability solutions under real testing conditions.

Composition of EAHP’s SIG 2.0 

The SIG will bring together a multidisciplinary working group of hospital pharmacists and vendor representatives, with hospital pharmacists retaining decision authority over the selection of use cases. Independent external experts may also be invited to contribute where relevant, without representing any participating vendor. 

Participation is open to organisations contributing to medication management interoperability, including: 

Timeline, envisioned output and funding requirements 

Following recruitment of the Core Working Group, SIG 2.0 will proceed according to the following indicative timeline: 

The SIG work plan is expected to deliver: 

Extending the SIG 1.0 methodology and existing FHIR Implementation Guide across the broader medication management process. This includes: 

  • Harmonising vendor specifications into a single, unambiguous protocol with no proprietary variants; 
  • Producing conformance statements supporting defined interoperability compliance tiers; 
  • Making the resulting protocol and guide openly accessible, free of charge, upon project completion. 

Demonstrated through structured testing and a live Showcase, including: 

  • Coordinated interoperability testing among participating vendor solutions ahead of the Congress; 
  • A pre-showcase validation exercise between participating vendors; 
  • A live, real-time multi-vendor demonstration at the 31st EAHP Congress in Vienna. 

SIG 2.0 combines: 

  • Pharmacist-led identification, analysis and documentation of priority use cases, including corresponding Standard Operating Procedures; 
  • Joint technical development of FHIR-based interoperability specifications, harmonised into a single protocol with one unambiguous binding per message type and no proprietary variants; 
  • Structured, coordinated interoperability testing between participating vendor solutions; 
  • Live, real-time interoperability validation at the Congress Showcase; 
  • Consensus-based governance, with Phase 2 technical decisions reached by agreement among participating vendors and moderated by the SIG co-chairs. 

All technical work will be governed by open standards principles and strict vendor-neutrality obligations, in compliance with EU competition law. 

By extending structured, pharmacist-led collaboration between hospital pharmacists and industry partners beyond automation devices, EAHP SIG 2.0 aims to advance a genuinely plug-and-play, closed-loop medication management ecosystem across Europe connecting prescribing, validation, dispensing, administration, monitoring, inventory management and automation. The initiative seeks to improve patient safety and operational efficiency across European hospital pharmacies, while informing future standardisation and policy work at the European level.